Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Rare Endocrine Disease Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Rare Endocrine Disease Treatmentmarket, defines the market attractiveness level of Rare Endocrine Disease Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Rare Endocrine Disease Treatment industry, describes the types of Rare Endocrine Disease Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Rare Endocrine Disease Treatment market and the development prospects and opportunities of Rare Endocrine Disease Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Rare Endocrine Disease Treatment market in Chapter 13.
By Player:
Corcept Therapeutics
Pfizer
EMD Serono
Teva
Novelion Therapeutics
Eli Lilly
Novartis
Novo Nordisk
Amgen
Ipsen
Takeda
By Type:
Biologics
Organic Compounds
By End-User:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Rare Endocrine Disease Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Rare Endocrine Disease Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Rare Endocrine Disease Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Rare Endocrine Disease Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Rare Endocrine Disease Treatment Market Analysis and Outlook to 2022
-
7.1 Global Rare Endocrine Disease Treatment Consumption (2017-2022)
-
7.2 United States Rare Endocrine Disease Treatment Consumption (2017-2022)
-
7.3 Europe Rare Endocrine Disease Treatment Consumption (2017-2022)
-
7.4 China Rare Endocrine Disease Treatment Consumption (2017-2022)
-
7.5 Japan Rare Endocrine Disease Treatment Consumption (2017-2022)
-
7.6 India Rare Endocrine Disease Treatment Consumption (2017-2022)
-
7.7 South Korea Rare Endocrine Disease Treatment Consumption (2017-2022)
8 Region and Country-wise Rare Endocrine Disease Treatment Market Analysis and Outlook to 2028
-
8.1 Global Rare Endocrine Disease Treatment Consumption Forecast (2022-2028)
-
8.2 United States Rare Endocrine Disease Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Rare Endocrine Disease Treatment Consumption Forecast (2022-2028)
-
8.4 China Rare Endocrine Disease Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Rare Endocrine Disease Treatment Consumption Forecast (2022-2028)
-
8.6 India Rare Endocrine Disease Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Rare Endocrine Disease Treatment Consumption Forecast (2022-2028)
9 Global Rare Endocrine Disease Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Rare Endocrine Disease Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biologics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Organic Compounds Consumption and Growth Rate (2017-2022)
-
9.2 Global Rare Endocrine Disease Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Rare Endocrine Disease Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Rare Endocrine Disease Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Biologics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Organic Compounds Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Rare Endocrine Disease Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Rare Endocrine Disease Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Rare Endocrine Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Rare Endocrine Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Rare Endocrine Disease Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Rare Endocrine Disease Treatment Market Competitive Analysis
-
14.1 Corcept Therapeutics
-
14.1.1 Corcept Therapeutics Company Details
-
14.1.2 Corcept Therapeutics Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Corcept Therapeutics Rare Endocrine Disease Treatment Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Rare Endocrine Disease Treatment Product and Service
-
14.3 EMD Serono
-
14.3.1 EMD Serono Company Details
-
14.3.2 EMD Serono Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 EMD Serono Rare Endocrine Disease Treatment Product and Service
-
14.4 Teva
-
14.4.1 Teva Company Details
-
14.4.2 Teva Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Teva Rare Endocrine Disease Treatment Product and Service
-
14.5 Novelion Therapeutics
-
14.5.1 Novelion Therapeutics Company Details
-
14.5.2 Novelion Therapeutics Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novelion Therapeutics Rare Endocrine Disease Treatment Product and Service
-
14.6 Eli Lilly
-
14.6.1 Eli Lilly Company Details
-
14.6.2 Eli Lilly Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eli Lilly Rare Endocrine Disease Treatment Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis Rare Endocrine Disease Treatment Product and Service
-
14.8 Novo Nordisk
-
14.8.1 Novo Nordisk Company Details
-
14.8.2 Novo Nordisk Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novo Nordisk Rare Endocrine Disease Treatment Product and Service
-
14.9 Amgen
-
14.9.1 Amgen Company Details
-
14.9.2 Amgen Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Amgen Rare Endocrine Disease Treatment Product and Service
-
14.10 Ipsen
-
14.10.1 Ipsen Company Details
-
14.10.2 Ipsen Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Ipsen Rare Endocrine Disease Treatment Product and Service
-
14.11 Takeda
-
14.11.1 Takeda Company Details
-
14.11.2 Takeda Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Takeda Rare Endocrine Disease Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Rare Endocrine Disease Treatment
-
Figure Rare Endocrine Disease Treatment Picture
-
Table Global Rare Endocrine Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rare Endocrine Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rare Endocrine Disease Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Rare Endocrine Disease Treatment Consumption by Country (2017-2022)
-
Figure United States Rare Endocrine Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Rare Endocrine Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Rare Endocrine Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Rare Endocrine Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Rare Endocrine Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Rare Endocrine Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Rare Endocrine Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Rare Endocrine Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Rare Endocrine Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Rare Endocrine Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Rare Endocrine Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Rare Endocrine Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Rare Endocrine Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biologics Consumption and Growth Rate (2017-2022)
-
Figure Global Organic Compounds Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Organic Compounds Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Rare Endocrine Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Rare Endocrine Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Corcept Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Corcept Therapeutics Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Corcept Therapeutics Rare Endocrine Disease Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Rare Endocrine Disease Treatment Product and Service
-
Table EMD Serono (Foundation Year, Company Profile and etc.)
-
Table EMD Serono Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table EMD Serono Rare Endocrine Disease Treatment Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Rare Endocrine Disease Treatment Product and Service
-
Table Novelion Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Novelion Therapeutics Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novelion Therapeutics Rare Endocrine Disease Treatment Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Rare Endocrine Disease Treatment Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Rare Endocrine Disease Treatment Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Rare Endocrine Disease Treatment Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Rare Endocrine Disease Treatment Product and Service
-
Table Ipsen (Foundation Year, Company Profile and etc.)
-
Table Ipsen Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen Rare Endocrine Disease Treatment Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Rare Endocrine Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Rare Endocrine Disease Treatment Product and Service
-
